Sudarshan Pharma acquires majority stake in Ishwari Healthcare
Sudarshan Pharma Industries (BSE: SUDARSHAN) announced today that it has successfully acquired 209,100 equity shares, representing 51% ownership, of Ishwari Healthcare Private Limited. The acquisition, effective April 1, 2025, makes Ishwari Healthcare a subsidiary of Sudarshan Pharma. The final consideration for the acquisition was revised to INR 15,000,000, a decrease from the initially proposed INR 26,000,000 following multiple rounds of negotiations. The shares were acquired from Mr. Shatrughan Nenwani at INR 71.73 per share. The company had initially disclosed its intent to acquire Ishwari Healthcare on October 14, 2024. This acquisition aligns with Sudarshan Pharma’s strategic growth initiatives.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
News Alerts
Get instant email alerts when SUDARSHAN PHARMA INDUSTRIES publishes news
Free account required • Unsubscribe anytime